What is the next step in managing a patient with a multinodular thyroid gland and bilateral solid nodules, including one with worrisome appearance and a calcified focus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Multinodular Thyroid Gland with Suspicious Nodules

Fine-needle aspiration biopsy (FNAB) should be performed on the worrisome nodule in the left lobe with internal vascularity (0.88 x 0.53 cm) and the calcified focus (0.62 x 0.54 cm), as these features suggest potential malignancy despite being less than 1 cm in size. 1

Rationale for FNAB

While most thyroid nodules are benign (approximately 95%), the presence of specific suspicious ultrasonographic features warrants further investigation even for nodules smaller than 1 cm 2, 1:

  • The nodule with internal vascularity in the left lobe (0.88 x 0.53 cm) shows concerning features
  • The calcified focus (0.62 x 0.54 cm) is particularly worrisome as microcalcifications are associated with papillary thyroid carcinoma
  • The multinodular appearance with heterogeneous texture and increased vascularity throughout the gland adds to the overall risk profile

Diagnostic Algorithm

  1. FNAB of suspicious nodules: Target the left lobe nodule with internal vascularity and the calcified focus 1

    • These nodules meet criteria for biopsy despite being <1 cm due to suspicious sonographic features
    • FNAB should be performed under ultrasound guidance for accuracy
  2. Laboratory assessment:

    • Thyroid function tests (TSH, free T4) to determine functional status
    • Consider serum calcitonin measurement to rule out medullary thyroid cancer 2
  3. Risk stratification based on FNAB results:

    • Benign: Follow-up with ultrasound in 6-12 months
    • Nondiagnostic: Repeat FNAB
    • Indeterminate/suspicious/malignant: Proceed to surgical consultation

Surgical Considerations

If FNAB results indicate malignancy or are highly suspicious:

  • For nodules ≥1 cm: Total or near-total thyroidectomy is the standard approach 2, 1
  • For nodules <1 cm with malignant cytology: The extent of surgery depends on risk factors
    • Unifocal, intrathyroidal tumors with favorable histology may be treated with lobectomy
    • Multifocal disease (as suggested by the multinodular appearance) may require total thyroidectomy 1

Follow-up Recommendations

If FNAB results are benign:

  • Regular ultrasound surveillance every 6-12 months initially, then annually if stable
  • Monitor for changes in size, appearance, or new suspicious features
  • Repeat FNAB if significant growth or development of new suspicious features occurs

Important Considerations

  • Surgical complications such as laryngeal nerve palsy and hypoparathyroidism are rare (<1-2%) when performed by experienced surgeons 1
  • The presence of multiple nodules increases the risk of missing a malignant lesion, making targeted FNAB of the most suspicious nodules crucial
  • Despite the small size of the suspicious nodules (<1 cm), their concerning ultrasound features override the general recommendation to observe nodules <1 cm 1, 3

The management approach prioritizes identifying potential malignancy while avoiding unnecessary procedures for benign disease, as this directly impacts patient morbidity, mortality, and quality of life.

References

Guideline

Management of Thyroid Cancer

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.